Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Nephrology (Carlton, Vic.)|December 26, 2018
Higher risk of malignant neoplasms in young adults with end-stage renal disease receiving haemodialysis: A nationwide population-based studyHeng-Chih Pan, Chiao-Yin Sun, I-Wen Wu, et al.
Archives of Pathology & Laboratory Medicine|March 21, 2022
Urinary Biomarkers Can Predict Weaning From Acute Dialysis Therapy in Critically Ill PatientsHeng-Chih Pan, Thomas Tao-Min Huang, Chun-Te Huang, et al.
BMJ Open|February 7, 2025
Clinical outcomes after immune checkpoint inhibitor-associated acute kidney injury: a cohort studyTing-Ya Yang, Min-Hsiang Chuang, Hong-Min Lin, et al.
International Journal of Biological Macromolecules|June 15, 2024
Modulation of gut microbiota by crude gac aril polysaccharides ameliorates diet-induced obesity and metabolic disordersTai-Jung Lu, Wei-Chung Chiou, Hsiu-Chen Huang, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 13, 2026
Cardiovascular and renal outcomes of combined SGLT2 inhibitors and GLP-1 receptor agonists versus monotherapy in patients with type 2 diabetes mellitus: a network meta-analysisMin-Hsiang Chuang, Cheng-Wei Ho, Hsien-Yi Wang, et al.
Kidney & Blood Pressure Research|October 14, 2020
Thermal Perception Abnormalities Can Predict Diabetic Kidney Disease in Type 2 Diabetes Mellitus PatientsWei-Ching Fang, Kuei-Mei Chou, Chiao-Yin Sun, et al.
Frontiers in Pharmacology|August 6, 2021
The Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers on Clinical Outcomes of Acute Kidney Disease Patients: A Systematic Review and Meta-AnalysisJui-Yi Chen, I-Jung Tsai, Heng-Chih Pan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2025
Kidney and Cardiovascular Outcomes Among Patients With CKD Receiving GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized TrialsJui-Yi Chen, Tsuen-Wei Hsu, Jung-Hua Liu, et al.
Nature Communications|November 20, 2024
The outcomes of SGLT-2 inhibitor utilization in diabetic kidney transplant recipientsJia-Yuh Sheu, Li-Yang Chang, Jui-Yi Chen, et al.
Clinical Kidney Journal|February 10, 2025
Dipeptidyl peptidase 4 inhibitors reduce the risk of adverse outcomes after acute kidney injury in diabetic patientsHung-Wei Liao, Chung-Yi Cheng, Hsing-Yu Chen, et al.
Pageof 9